Time
Tuesday December 13,
2022
Wednesday December 14,
2022
Thursday December, 15,
2022
Friday December 16,
2022
08:00
10:00
AM
SESSION 1 :
Basic Science
of HIV
Latency
SESSION 4 :
Immunology
of HIV
Persistence
SESSION 7 :
Human studies
and drug
development II
10:00
10:30
PM
Bill & Melinda Gates Foundation Symposium
Coffee break
Coffee break
Coffee break
10:30
AM
12:00
PM
Bill & Melinda Gates Foundation Symposium
SESSION 2 :
In Vitro and Animal
Model Studies
of HIV Persistence
SESSION 5 :
Human studies
and drug
development I
SESSION 8 :
New
Therapeutic
Approaches II
12:00
PM
12:30
PM
Lunch on your own
SESSION 2 :
In Vitroand Animal
Model Studies
of HIV Persistence
SESSION 5 :
Human studies
and drug
development I
SESSION 8 :
New
Therapeutic
Approaches II
12:30
01:30
PM
Lunch on your own
Lunch
Lunch
Closing Ceremony
01:30
02:00
PM
NIH Martin Delaney Collaboratories symposium
Lunch
Lunch
2:00
3:30
PM
NIH Martin Delaney Collaboratories symposium
SESSION 3 :
Virology
of HIV Persistence
SESSION 6 :
New Therapeutic
Approaches I
3:30
4:00
PM
Coffee break
SESSION 3 :
Virology
of HIV Persistence
SESSION 6 :
New Therapeutic
Approaches I
04:00
05:00
PM
NIH Martin Delaney Collaboratories symposium
Young investigators’
abstract presentations
Young investigators’
abstract presentations
05:00
06:25
PM
NIH Martin Delaney Collaboratories symposium
Poster viewing
with wine
and cheese tasting
Poster viewing
with wine
and cheese tasting
06:25
07:00
PM
Opening Lecture
Poster viewing
with wine
and cheese tasting
Poster viewing
with wine
and cheese tasting
7:00
PM
Welcome Dinner
Evening Dinner On Your Own
Evening Dinner On Your Own
PROGRAM DAY BY DAY
10:00 AM – 12:00 PM – Bill & melinda Gates foundation symposium
12:00 – 1:30 pm – Lunch on your own
1:30 pm – 3:35pm – NIH Martin Delaney Collaboratories symposium
03:40 – 04:10 PM – Coffee Break
04:10 – 06:25 PM – NIH Martin Delaney Collaboratories symposium
06:30 – 07:00 PM – Opening Lecture « Tribute to Timothy Ray Brown »
Welcoming message – Alain Lafeuillade, La Valette du Var, France – Mario Steveson, Miami, USA – David Margolis, Chapel Hill, USA – Karl Salzwedel, Bethesda, USA
Lessons learned from allogeneic stem cell transplantation in HIV+ patients Gero Hütter, Germany
07:00 PM – Welcome dinner
08:00 – 10:00 AM Session 1: Basic Science of HIV Persistence
Moderators: Maria Salgado, Barcelona – SPA & Nancy Archin, Chapell Hill – USA
1st lecturer: Sequencing HIV: Significance and Impact- Sarah Palmer, Sydney – AUS
+ 7 oral communications
10:00 – 10:30 AM Break
10:30 AM – 12:30 PM Session 2: In Vitro and Animal Model Studies of HIV Persistence
Moderators: Ann Chahroudi, Yerkes – USA & Afam Okoye, Beaverton – USA
1st lecturer: CCR5 blockade in HIV cure – Jonah B. Sacha, Beaverton, USA
+ 7 oral communications
12:30 – 02:00 PM – Lunch
02:00 – 04:00 PM – Session 3: Virology of HIV Persistence
Moderators: Ya Chi Ho, Yale – USA & Mary Kearney, Frederick – USA
1st lecturer: TBD – Nancie Archin, USA
+ 7 oral communications
04:00 – 05:00 PM – Young investigators dedicated session for oral presentations
05:00 – 07:30 PM – Poster session & free evening dinner
05:00 – 07:30 PM – Poster session & free evening dinner
08:00 – 10:00 AM Session 4: Immunology of HIV Persistence
Moderators: Katharine Bar, Philadelphia – USA & Bradley Jones, New York – USA
1st lecturer: Viral persistence and NK cells – Michaela Muller–Trutwin, Paris, France
+ 7 oral communications
10:00 – 10:30 AM Break
10:30 AM – 12:30 PM Session 5: Drug Discovery Development & pharmacology
Moderators: Romas Geleziunas, Foster City – USA & Jan Van Luzen, London – GB
1st lecturer: IAP inhibitors to induce HIV expression- Richard Dunham, Chapel Hill, USA
+ 7 oral communications
12:30 – 02:00 PM – Lunch
02:00 – 04:00 PM – Session 6: Cell & gene therapies
Moderators: Javier Martinez-Picado, Badalona – ESP & Paula Cannon, Los Angeles – USA
1st lecturer: It’s a mountain not a hill: Progress made in realizing AAV-delivered inhibitors for an HIV cure – Mathew Gardner, Jupiter, USA
+ 7 oral communications
04:00 – 05:00 PM – Young investigators dedicated session for oral presentations
05:00 – 07:30 PM – Poster session & free evening dinner
08:00 – 10:00 AM Session 7: Human Studies
Moderators: L.ydie Trautman, Beaverton – USA & Thumbi Ndudng’u, Durban – South Africa*
1st lecturer: Challenges and Advances in Identification and Immune Targeting of HIV-Infected Cells: Implications for HIV Cure Therapies – Timothy Henrich, San Francisco, USA
+ 7 oral communications
10:00 – 10:30 AM Break
10:30 AM – 12:30 PM Session 8: Antibody & Immune based therapies
Moderators: Marina Caskey, Rockefeller – USA & Michael Farzan, San Diego – USA
1st lecturer: Broadly Neutralizing Antibodies for HIV Prevention, Therapy and Cure: 3BNC117 & 10-1074 Studies – Marina Caskey, New York , USA
+ 7 oral communications
12:30 – 01:00 PM – Closing ceremony